Clinical Trial Update: Tenofovir DF (Disoproxil Fumarate) in Combination With Emtricitabine in HIV-1 Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating a combination of tenofovir disoproxil fumarate and emtricitabine in HIV-1 patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Emtriva (emtricitabine)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV Infections | Phase 4 | Status: COMPLETED